Literature DB >> 1550597

The human multidrug resistance 1 promoter has an element that responds to serum starvation.

H Tanimura1, K Kohno, S Sato, T Uchiumi, M Miyazaki, M Kobayashi, M Kuwano.   

Abstract

We have previously demonstrated in transient expression assay systems that a human multidrug resistance 1 (MDR1) promoter can be directly activated by cytotoxic anticancer agents. In this study, we examined whether the MDR1 promoter could be regulated in response to growth arrest induced by serum starvation. We have established human and rodent cell lines which stably expressed the chloramphenicol acetyltransferase (CAT) gene driven by various lengths of the MDR1, the viral thymidine kinase (TK) and the simian virus 40 (SV40) promoters. Serum starvation caused enhanced expression of CAT gene with MDR1 promoter, but not with two viral gene promoters in human cancer KB cells. Hydroxyurea activated the MDR1 promoter, but not TK and SV40 promoters. By contrast, the DNA topoisomerase II inhibitor, etoposide, equally activated the MDR1, TK and SV 40 promoters. Increased CAT gene expression by serum starvation was also specifically observed in stable transfectants of human adrenal SW-13 cell lines, but not in stable transfectants of mouse fibroblast NIH3T3 and adrenal Y-1 cell lines when the human MDR1 promoter-CAT was introduced. Etoposide, however, effectively induced CAT activity in both human and rodent cells. Assays with deletion constructs of the MDR1 promoter showed that serum starvation activated the MDR1 promoter carrying -258 approximately +121 base sequence of the promoter, but not -198 approximately +121 of the promoter. These results suggest that the expression of the MDR1 gene induced by serum starvation is regulated at the transcriptional level in a promoter sequence-specific manner in human cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1550597     DOI: 10.1016/0006-291x(92)90571-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Structural and functional analysis of the human Y-box binding protein (YB-1) gene promoter.

Authors:  Y Makino; T Ohga; S Toh; K Koike; K Okumura; M Wada; M Kuwano; K Kohno
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

Review 2.  Multidrug resistance (MDR) genes in haematological malignancies.

Authors:  K Nooter; P Sonneveld
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

3.  Vincristine induction of mutant and wild-type human multidrug-resistance promoters is cell-type-specific and dose-dependent.

Authors:  U Stein; W Walther; R H Shoemaker
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 4.  Transcriptional regulation of multidrug resistance in breast cancer.

Authors:  R I Glazer; C Rohlff
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

5.  Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.

Authors:  X F Hu; A Slater; D Rischin; P Kantharidis; J D Parkin; J Zalcberg
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

6.  Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line.

Authors:  X F Hu; A Slater; D M Wall; P Kantharidis; J D Parkin; A Cowman; J R Zalcberg
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

7.  Purification and characterization of NF-R2 that regulates the expression of the human multidrug resistance (MDR1) gene.

Authors:  T Takatori; M Ogura; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1993-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.